Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension

The Egyptian Journal of Internal Medicine

Table 2 The mean HbA1c difference between the telmisartan and Azilsartan groups

	Drugs	Baseline	6 Months	P value
Fasting blood sugar (mg/dl)	Telmisartan	170.74 \(\pm\) 74.41	140.45 \(\pm\) 75.30	0.091
Fasting blood sugar (mg/dl)	Azilsartan	171.32 \(\pm\) 56.90	156.29 \(\pm 47.51\)	0.000
Post prandial blood sugar (mg/dl)	Telmisartan	228.13 \(\pm 89.64\)	178.58 \(\pm 39.82\)	0.000
Post prandial blood sugar (mg/dl)	Azilsartan	228.10 \(\pm 78.46\)	201.58 \(\pm 47.59\)	0.004
HbA1c (%)	Telmisartan	8.9 \(\pm 1.72\)	7.4 \(\pm 0.74\)	0.000
HbA1c (%)	Azilsartan	8.9 \(\pm 1.99\)	8.7 \(\pm 1 .70\)	0.212